EVO X30 Diagnostic Ultrasound System; EVO X20 Diagnostic Ultrasound System; EVO X10 Diagnostic Ultrasound System; EVO XP30 Diagnostic Ultrasound System; EVO XP20 Diagnostic Ultrasound System; EVO XP10 Diagnostic Ultrasound System; EVO XC30 Diagnostic Ultrasound System; EVO XC20 Diagnostic Ultrasound System; EVO XC10 Diagnostic Ultrasound System
Samsung Medison Co., Ltd. · Decision date Sep 25, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 2026-09-25 for K263182, a traditional 510(k) from Samsung Medison Co., Ltd. covering nine EVO-series diagnostic ultrasound systems: the X30, X20, X10, XP30, XP20, XP10, XC30, XC20 and XC10. The application was received 09/11/2026 under regulation 892.1550, product code IYN, with subsequent codes ITX, IYO and LLZ, in the Radiology specialty and review panel. SESE denotes clearance to market, not PMA approval.
The record shows the review was conducted by a third party, with Regulatory Technology Services, LLC as correspondent and Prithul Bom as correspondent contact. A document excerpt states the EVO XC20 and EVO XC10 systems are substantially equivalent to the predicate device regarding intended use, imaging capabilities, technological characteristics and safety, but the full predicate identity, the specific changes from prior EVO models, and any performance data are not given in the available text.
The public page lists no summary statement, and the source does not identify which predicate device was cited or what, if anything, distinguishes these models from earlier clearances. No clinical, efficacy or labeling conclusions are drawn here.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Radiology
- Decision date
- Sep 25, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K263182
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Samsung Medison Co., Ltd.
- Product code
- IYN
- Decision code
- SESE
- Decision date
- Sep 25, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: System, Imaging, Pulsed Doppler, Ultrasonic.
- Applicant
- Samsung Medison Co., Ltd.
- Product code
- IYN
- FDA device class
- 2
FDA decision timeline
K263182 received
Application receipt date recorded by FDA.
K263182 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code IYN
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Shenzhen Mindray Bio-Medical Electronics Co., Ltd. | 510(k) clearance | Oct 16, 2026 | FDA | |
| Shenzhen Mindray Bio-Medical Electronics Co., Ltd. | 510(k) clearance | Oct 8, 2026 | FDA | |
| Samsung Medison Co., Ltd. | 510(k) clearance | Oct 8, 2026 | FDA | |
| GE Medical Systems Ultrasound and Primary care Diagnostics, LLC | 510(k) clearance | Oct 2, 2026 | FDA | |
| Philips Ultrasound, LLC | 510(k) clearance | Sep 25, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Samsung Medison Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Hongcheon-Gun
Sources and methodology
- Original FDA record: K263182
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


